Virongy Biosciences
PrivateLast Round
Corporate Funding
May 17, 2022
Total Funding Raised
$471,000
Company Overview
Virongy Biosciences operates in Healthcare & Life Sciences and is based in Manassas, Virginia. Its latest recorded funding round was a Corporate Funding round in May 2022.
Virongy Biosciences is a biotechnology company that provides research platforms, viral diagnostic tools, and laboratory services for virology and gene therapy research.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Virongy Biosciences Comparables
Compare Virongy Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BPS Bioscience | 78% | |
| CellBio Scientific | 72% | |
| Sartorius Aktiengesellschaft | 66% |
For institutional investors. Book with your work email.
Virongy Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | May 17, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Virongy Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Prince William County Department of Economic Development and Tourism | Grant |
| NIH RADx | Grant |
| Virginia Economic Development Partnership | Corporate Funding |
| Virginia Jobs Investment Program | Corporate Funding |
Virongy Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Virongy Biosciences's valuation, stock price, and market status.
Is Virongy Biosciences a public or private company?
Virongy Biosciences is a private company.
What is the current stock price of Virongy Biosciences?
Virongy Biosciences is a private company, so its shares have no public market price. Caplight tracks Virongy Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Virongy Biosciences worth (valuation)?
Valuation information for Virongy Biosciences is not publicly available.
Can I buy Virongy Biosciences stock?
Virongy Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Virongy Biosciences's last funding round?
Virongy Biosciences's most recent funding round was Corporate Funding on May 17, 2022.
Who are the main investors in Virongy Biosciences?
Key investors in Virongy Biosciences include Prince William County Department of Economic Development and Tourism, NIH RADx, Virginia Economic Development Partnership, Virginia Jobs Investment Program.
Will Virongy Biosciences IPO soon?
No public IPO plans have been announced for Virongy Biosciences.
How can I track Virongy Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Virongy Biosciences's shares on secondary markets.